4 Jul 2025

Reference: CIR-2025-00000120

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

Circular No. 07  Safety Update of Product Contains Cetirizine or Levocetirizine.

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA